Sign in

CIK 0001347178

  • Accelerated filer

Vanda Pharmaceuticals Inc.

Sign in to watch
Ticker
VNDA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
030491827
Phone
+1 202-734-3400
Business address
2200 PENNSYLVANIA AVE NW, SUITE 300E, WASHINGTON, DC, 20037
  1. 4 Grant or award Director acquired 5,000 shares (grant or award)
  2. 4 Grant or award Director acquired 5,000 shares (grant or award)
  3. 4 Grant or award Director acquired 5,000 shares (grant or award)
  4. 4 Grant or award Director acquired 5,000 shares (grant or award)
  5. 4 Exercise or conversion Director acquired 15,000 shares (option exercise)
  6. 4 Exercise or conversion Director acquired 15,000 shares (option exercise)
  7. 4 Grant or award SVP & Chief Commercial Officer acquired 30,000 shares (grant or award)
  8. 4 Open-market sale President and CEO sold 60,966 shares at $18.72 ($1,141,003)
  9. 4 Open-market sale EVP & Chief Financial Officer sold 8,532 shares at $18.72 ($159,712)
  10. 4 Open-market sale SVP, General Counsel & Sec. sold 3,660 shares at $18.71 ($68,473)
  11. 4 Open-market sale SVP, Business Development sold 8,525 shares at $18.72 ($159,605)
  12. 4 Exercise or conversion SVP & Chief Commercial Officer acquired 20,000 shares (option exercise)
  13. 4 Open-market sale President and CEO sold 191,760 shares at an average $15.30 ($2,933,127)
  14. 4 Open-market sale EVP & Chief Financial Officer sold 9,155 shares at $15.35 ($140,494)
  15. 4 Open-market sale SVP, General Counsel & Sec. sold 10,367 shares at $15.20 ($157,565)
  16. 4 Open-market sale SVP, Business Development sold 8,568 shares at $15.26 ($130,777)
  17. 4 Grant or award Director acquired 5,000 shares (grant or award)
  18. 4 Grant or award Director acquired 5,000 shares (grant or award)
  19. 4 Grant or award Director acquired 5,000 shares (grant or award)
  20. 4 Grant or award Director acquired 5,000 shares (grant or award)

Page 11 of 29 · 579 filings